BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26725957)

  • 21. Stereotactic Body Radiation Therapy in Primary and Metastatic Liver Disease.
    Caivano D; Valeriani M; Russo I; Bonome P; DE Matteis S; Minniti G; Osti MF
    Anticancer Res; 2017 Dec; 37(12):7005-7010. PubMed ID: 29187487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors.
    Kirichenko A; Gayou O; Parda D; Kudithipudi V; Tom K; Khan A; Abrams P; Szramowski M; Oliva J; Monga D; Raj M; Thai N
    HPB (Oxford); 2016 Jan; 18(1):88-97. PubMed ID: 26776856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions.
    Takeda A; Sanuki N; Tsurugai Y; Oku Y; Aoki Y
    J Radiat Res; 2016 Jul; 57(4):400-5. PubMed ID: 26983981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic Body Radiation Therapy (SBRT) for lung metastases.
    Okunieff P; Petersen AL; Philip A; Milano MT; Katz AW; Boros L; Schell MC
    Acta Oncol; 2006; 45(7):808-17. PubMed ID: 16982544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results.
    Carvajal C; Navarro-Martin A; Cacicedo J; Ramos R; Guedea F
    J BUON; 2015; 20(1):158-65. PubMed ID: 25778311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Stereotactic body radiation therapy for patients with lung and liver oligometastases from colorectal cancer: a phase Ⅱ trial].
    Lei JQ; Liu WY; Tang Y; Tang Y; Li N; Ren H; Yihebali C; Sun YK; Zhang W; Bi XY; Zhao JJ; Fang H; Lu NN; Zhou AP; Wang SL; Song YW; Liu YP; Chen B; Qi SN; Cai JQ; Li YX; Jin J
    Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):282-290. PubMed ID: 35316879
    [No Abstract]   [Full Text] [Related]  

  • 27. Stereotactic body radiation therapy for liver metastases.
    Dawood O; Mahadevan A; Goodman KA
    Eur J Cancer; 2009 Nov; 45(17):2947-59. PubMed ID: 19773153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study on stereotactic body radiotherapy of colorectal metastases.
    Hoyer M; Roed H; Traberg Hansen A; Ohlhuis L; Petersen J; Nellemann H; Kiil Berthelsen A; Grau C; Aage Engelholm S; Von der Maase H
    Acta Oncol; 2006; 45(7):823-30. PubMed ID: 16982546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic body radiation therapy for colorectal cancer liver metastases; early results.
    Burkon P; Slampa P; Kazda T; Slavik M; Prochazka T; Vrzal M
    Klin Onkol; 2012; 25 Suppl 2():2S93-7. PubMed ID: 23581024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypofractionated stereotactic body radiotherapy for primary and metastatic liver tumors using the novalis image-guided system: preliminary results regarding efficacy and toxicity.
    Iwata H; Shibamoto Y; Hashizume C; Mori Y; Kobayashi T; Hayashi N; Kosaki K; Ishikawa T; Kuzuya T; Utsunomiya S
    Technol Cancer Res Treat; 2010 Dec; 9(6):619-27. PubMed ID: 21070084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic radiation therapy for liver metastases: factors affecting local control and survival.
    Andratschke NH; Nieder C; Heppt F; Molls M; Zimmermann F
    Radiat Oncol; 2015 Mar; 10():69. PubMed ID: 25889512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors Greater Than 5 cm: Safety and Efficacy.
    Woody NM; Stephans KL; Marwaha G; Djemil T; Videtic GM
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):325-31. PubMed ID: 25841625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel strategy in the treatment of liver metastases - Hepatic resection combined with stereotactic body radiotherapy.
    Ihnát P; Skácelíková E; Vávra P; Jonszta T; Ihnát Rudinská L; Tomášková H
    Asian J Surg; 2020 Sep; 43(9):902-906. PubMed ID: 31911035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
    Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes of single dose stereotactic radiotherapy for lung metastases.
    Osti MF; Carnevale A; Valeriani M; De Sanctis V; Minniti G; Cortesi E; Martelli M; Maurizi Enrici R
    Clin Lung Cancer; 2013 Nov; 14(6):699-703. PubMed ID: 23886798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
    Méndez Romero A; Wunderink W; Hussain SM; De Pooter JA; Heijmen BJ; Nowak PC; Nuyttens JJ; Brandwijk RP; Verhoef C; Ijzermans JN; Levendag PC
    Acta Oncol; 2006; 45(7):831-7. PubMed ID: 16982547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study.
    Nuyttens JJ; van der Voort van Zyp NC; Verhoef C; Maat A; van Klaveren RJ; van der Holt B; Aerts J; Hoogeman M
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):337-43. PubMed ID: 25636758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday.
    Lazzari R; Ronchi S; Gandini S; Surgo A; Volpe S; Piperno G; Comi S; Pansini F; Fodor C; Orecchia R; Tomao F; Parma G; Colombo N; Jereczek-Fossa BA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):650-660. PubMed ID: 29893277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up.
    Scorsetti M; Comito T; Clerici E; Franzese C; Tozzi A; Iftode C; Di Brina L; Navarria P; Mancosu P; Reggiori G; Fogliata A; Tomatis S; Torzilli G; Cozzi L
    Radiat Oncol; 2018 Nov; 13(1):234. PubMed ID: 30477560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.